These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37494554)

  • 21. Fecal transplantation for treatment of inflammatory bowel disease.
    Imdad A; Nicholson MR; Tanner-Smith EE; Zackular JP; Gomez-Duarte OG; Beaulieu DB; Acra S
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012774. PubMed ID: 30480772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using Diet to Treat Inflammatory Bowel Disease: A Systematic Review.
    Gleave A; Shah A; Tahir U; Blom JJ; Dong E; Patel A; Marshall JK; Narula N
    Am J Gastroenterol; 2024 Jul; ():. PubMed ID: 39056556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.
    Cox SR; Lindsay JO; Fromentin S; Stagg AJ; McCarthy NE; Galleron N; Ibraim SB; Roume H; Levenez F; Pons N; Maziers N; Lomer MC; Ehrlich SD; Irving PM; Whelan K
    Gastroenterology; 2020 Jan; 158(1):176-188.e7. PubMed ID: 31586453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical value of fecal calprotectin for evaluating disease activity in patients with Crohn's disease.
    Li J; Xu M; Qian W; Ling F; Chen Y; Li S; Cheng Y; Zhu L
    Front Physiol; 2023; 14():1186665. PubMed ID: 37324392
    [No Abstract]   [Full Text] [Related]  

  • 25. Glutamine for induction of remission in Crohn's disease.
    Akobeng AK; Elawad M; Gordon M
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD007348. PubMed ID: 26853855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease.
    Hoekman DR; Diederen K; Koot BG; Tabbers MM; Kindermann A; Benninga MA
    Eur J Pediatr; 2016 Oct; 175(10):1335-42. PubMed ID: 27573259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The combination of fecal calprotectin with ESR, CRP and albumin discriminates more accurately children with Crohn's disease.
    Daniluk U; Daniluk J; Krasnodebska M; Lotowska JM; Sobaniec-Lotowska ME; Lebensztejn DM
    Adv Med Sci; 2019 Mar; 64(1):9-14. PubMed ID: 30237086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discordant erythrocyte sedimentation rate and C-reactive protein in children with inflammatory bowel disease taking azathioprine or 6-mercaptopurine.
    Barnes BH; Borowitz SM; Saulsbury FT; Hellems M; Sutphen JL
    J Pediatr Gastroenterol Nutr; 2004 May; 38(5):509-12. PubMed ID: 15097439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nutritional and dietary strategy in the clinical care of inflammatory bowel disease.
    Hsieh MS; Hsu WH; Wang JW; Wang YK; Hu HM; Chang WK; Chen CY; Wu DC; Kuo FC; Su WW
    J Formos Med Assoc; 2020 Dec; 119(12):1742-1749. PubMed ID: 31624009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS.
    Menees SB; Powell C; Kurlander J; Goel A; Chey WD
    Am J Gastroenterol; 2015 Mar; 110(3):444-54. PubMed ID: 25732419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of Dietary Interventions on the Symptoms of Inflammatory Bowel Disease: A Systematic Review.
    Charlebois A; Rosenfeld G; Bressler B
    Crit Rev Food Sci Nutr; 2016 Jun; 56(8):1370-8. PubMed ID: 25569442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nutritional management of inflammatory bowel disease; an overview of the evidences.
    Morshedzadeh N; Rahimlou M; Shahrokh S; Mirmiran P; Zali MR
    Diabetes Metab Syndr; 2022 Mar; 16(3):102440. PubMed ID: 35247656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein.
    Takeyama H; Mizushima T; Iijima H; Shinichiro S; Uemura M; Nishimura J; Hata T; Takemasa I; Yamamoto H; Doki Y; Mori M
    Dig Dis Sci; 2015 Nov; 60(11):3418-23. PubMed ID: 26077975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comprehensive review and update on Crohn's disease.
    Gajendran M; Loganathan P; Catinella AP; Hashash JG
    Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Food avoidance, restrictive eating behaviour and association with quality of life in adults with inflammatory bowel disease: A systematic scoping review.
    Day AS; Yao CK; Costello SP; Andrews JM; Bryant RV
    Appetite; 2021 Dec; 167():105650. PubMed ID: 34391842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-Fat, High-Fiber Diet Reduces Markers of Inflammation and Dysbiosis and Improves Quality of Life in Patients With Ulcerative Colitis.
    Fritsch J; Garces L; Quintero MA; Pignac-Kobinger J; Santander AM; Fernández I; Ban YJ; Kwon D; Phillips MC; Knight K; Mao Q; Santaolalla R; Chen XS; Maruthamuthu M; Solis N; Damas OM; Kerman DH; Deshpande AR; Lewis JE; Chen C; Abreu MT
    Clin Gastroenterol Hepatol; 2021 Jun; 19(6):1189-1199.e30. PubMed ID: 32445952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. British Dietetic Association evidence-based guidelines for the dietary management of Crohn's disease in adults.
    Lee J; Allen R; Ashley S; Becker S; Cummins P; Gbadamosi A; Gooding O; Huston J; Le Couteur J; O'Sullivan D; Wilson S; Lomer MC;
    J Hum Nutr Diet; 2014 Jun; 27(3):207-18. PubMed ID: 24313460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal calprotectin as a marker of the severity of mucosal inflammation in children with inflammatory bowel disease.
    Dolinšek J; Rižnik P; Sabath L; Mičetić-Turk D
    Wien Klin Wochenschr; 2016 Apr; 128(7-8):253-9. PubMed ID: 26659704
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.